Terms: = Lung cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Staging
36 results:
1. Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge - A systematic review.
Müller M; Li J; Giger R; Elicin O
Oral Oncol; 2023 Oct; 145():106529. PubMed ID: 37506514
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
[TBL] [Abstract] [Full Text] [Related]
3. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of Methylation Panel in the Promoter Region of
Mohammed F; Baydaa Abed Hussein A; Ahmed T
Arch Razi Inst; 2022 Jun; 77(3):1075-1081. PubMed ID: 36618318
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of the interactions between small pulmonary nodules, clinical factors and the risk of malignancy in the chest following diagnosis of head and neck cancer.
Macmillan MT; Hopkins ME; Gomati A; Subedi D; Reid H; Bruce L; Murchison JT; Nixon IJ
Clin Otolaryngol; 2022 May; 47(3):455-463. PubMed ID: 35212150
[TBL] [Abstract] [Full Text] [Related]
6. The highlights of the 15th international conference of the international mesothelioma interest group - Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?
Klebe S; Galateau Salle F; Bruno R; Brcic L; I Chen-Yost H; Jaurand MC
Lung Cancer; 2022 Jan; 163():1-6. PubMed ID: 34864334
[TBL] [Abstract] [Full Text] [Related]
7. Malignant pleural mesothelioma: recent developments.
Sinn K; Mosleh B; Hoda MA
Curr Opin Oncol; 2021 Jan; 33(1):80-86. PubMed ID: 33186182
[TBL] [Abstract] [Full Text] [Related]
8. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A; Opitz I; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell D; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Cardillo G; Putora PM
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32451346
[TBL] [Abstract] [Full Text] [Related]
9. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Opitz I; Scherpereel A; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell DA; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Putora PM; Cardillo G
Eur J Cardiothorac Surg; 2020 Jul; 58(1):1-24. PubMed ID: 32448904
[TBL] [Abstract] [Full Text] [Related]
10. A Regulatory Noncoding RNA, nc886, Suppresses Esophageal cancer by Inhibiting the AKT Pathway and Cell Cycle Progression.
Im WR; Lee HS; Lee YS; Lee JS; Jang HJ; Kim SY; Park JL; Lee Y; Kim MS; Lee JM; Kim IH; Jeon SH; Lee YS
Cells; 2020 Mar; 9(4):. PubMed ID: 32225025
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell lung cancer; Relationship With Ki-67 and PD-L1.
Pezzuto A; Cappuzzo F; D'Arcangelo M; Ciccozzi M; Navarini L; Guerrini S; Ricci A; D'Ascanio M; Carico E
Anticancer Res; 2020 Feb; 40(2):983-990. PubMed ID: 32014943
[TBL] [Abstract] [Full Text] [Related]
12. New p16 Expression Criteria Predict Lymph Node Metastasis in Patients With Non-small Cell lung cancer.
An HJ; Koh HM; Song DH
In Vivo; 2019; 33(6):1885-1892. PubMed ID: 31662516
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
[TBL] [Abstract] [Full Text] [Related]
14. HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features.
Bishop JA; Andreasen S; Hang JF; Bullock MJ; Chen TY; Franchi A; Garcia JJ; Gnepp DR; Gomez-Fernandez CR; Ihrler S; Kuo YJ; Lewis JS; Magliocca KR; Pambuccian S; Sandison A; Uro-Coste E; Stelow E; Kiss K; Westra WH
Am J Surg Pathol; 2017 Dec; 41(12):1690-1701. PubMed ID: 28877065
[TBL] [Abstract] [Full Text] [Related]
15. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
Schneider F; Derrick V; Davison JM; Strollo D; Incharoen P; Dacic S
Mod Pathol; 2016 Jul; 29(7):735-42. PubMed ID: 27080983
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
[TBL] [Abstract] [Full Text] [Related]
17. Assessment of methylation status of locoregional lymph nodes in lung cancer using EBUS-NA.
Millares L; Serra M; Andreo F; Sanz-Santos J; Montón C; Grimau C; Gallego M; Setó L; Combalia N; Llatjos M; Escoda R; Castellà E; Monsó E
Clin Exp Metastasis; 2015 Oct; 32(7):637-46. PubMed ID: 26119430
[TBL] [Abstract] [Full Text] [Related]
18. Biological Marker Analysis as Part of the CIBERES-RTIC cancer-SEPAR Strategic Project on lung cancer.
Monsó E; Montuenga LM; Sánchez de Cos J; Villena C;
Arch Bronconeumol; 2015 Sep; 51(9):462-7. PubMed ID: 25614375
[TBL] [Abstract] [Full Text] [Related]
19. Viability of lymph node samples obtained by echobronchoscopy in the study of epigenetic alterations in patients with lung cancer.
Leiro-Fernández V; De Chiara L; Botana-Rial M; González-Piñeiro A; Tardio-Baiges A; Núñez-Delgado M; Valverde Pérez D; Fernández-Villar A
Arch Bronconeumol; 2014 Jun; 50(6):213-20. PubMed ID: 24388707
[TBL] [Abstract] [Full Text] [Related]
20. Primary and secondary leiomyosarcoma of the oral and perioral region--clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature.
Schütz A; Smeets R; Driemel O; Hakim SG; Kosmehl H; Hanken H; Kolk A
J Oral Maxillofac Surg; 2013 Jun; 71(6):1132-42. PubMed ID: 23434173
[TBL] [Abstract] [Full Text] [Related]
[Next]
